- Childhood AML Combined with AML1-ETO Fusion Gene and c-KIT or Other Mutations Had Favorable Survival Treated By the C-Huanan AML 2015 Protocol: Study in Multicenter of South of ChinaFeng, Xiaoqin; Li, Chunfu; Li, Jian; Zheng, Yongzhi; Zheng, Mincui; Mai, Huirong; Yang, Lihua; He, Xiangling; He, Yingyi; Wen, Hong; Li, Yirong65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- Gene Mutation and MRD-Directed Risk Stratification Treatment Improves Long Term Survival of the Patients with AML1-ETO-Positive AMLXu, Dan; Yang, Ying; Yin, Zhao; Tu, Sanfang; Nie, Danian; Sun, Qixin; Huang, Zhengqian; Zhang, Yu; Yu, Guopan64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.
- EBF1 Promotes Cell Proliferation, Migration and Inhibits Cell Apoptosis in AMLZhou, Ya; Luo, Tingyue; Xue, Rongtao; Liu, Qifa; Hui, Liu64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.
会议论文
Genetic Variation and Survival Analysis of Childhood AML By C-Huanan AML 2015 Protocol in China:Multicenter Clinical Study in 546 Cases
8阅读
